Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04241562 · ClinicalTrials.gov registry record
Validation of a Novel Cortical Biomarker Signature for Pain
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 159
- Enrollment target
NCT04241562 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 159 participants.
The verdict
NCT04241562 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 159 participants
- Enrollment target
Study Summary
The study aims to undertake analytical validation of an brain biomarker in healthy participants experiencing a model of sustained temporomandibular pain. The biomarker could detect participants at greater risk of developing more severe pain.
Interventions
- OTHER Injection of Nerve Growth Factor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2020-11-04 |
| Est. Completion | 2022-10-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04241562
The ClinicalTrials.gov registry entry for NCT04241562 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Injection of Nerve Growth Factor is the first listed.
NCT04241562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04241562 about?
NCT04241562 is a clinical study titled "Validation of a Novel Cortical Biomarker Signature for Pain". The study aims to undertake analytical validation of an brain biomarker in healthy participants experiencing a model of sustained temporomandibular pain. The biomarker could detect participants at greater risk of developing more severe pain.
What is the current status of trial NCT04241562?
This trial is currently completed. The enrollment target is 159 participants. The study started on 2020-11-04. Estimated completion is 2022-10-10.
What interventions are being tested in trial NCT04241562?
The interventions under investigation include: Injection of Nerve Growth Factor (OTHER).
Who is sponsoring clinical trial NCT04241562?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.